[ Price : $8.95]
President Obama signs into law a spending measure for FY 2012 that gives the agency $2.5 billion or $50 million (2%) more than FY ...[ Price : $8.95]
FDA approves the removal of a bioscan requirement for Non-Hodgkin lymphoma patients receiving Spectrum Pharmaceutical's Zevalin th...[ Price : $8.95]
A federal judge sentences former Synthes chief operating officer Michael Huggins to nine months in jail after pleading guilty to a...[ Price : $8.95]
Mylan says it has settled patent litigation with Novartis Pharmaceuticals involving a Mylan ANDA for a generic copy of Vivelle-Dot...[ Price : $8.95]
FDA extends by three months its review of Takeda Pharmaceutical NDAs for the investigational Type 2 diabetes therapy alogliptin, a...[ Price : $8.95]
In an anticipated move, FDA issues a revocation order on a metastatic breast cancer indication for Genentechs Avastin (bevacizumab...[ Price : $8.95]
Washington commentator Robert F. Steeves congratulates commissioner Hamburg and FDA for apparently following his advice in conveni...[ Price : $8.95]
FDA approves an EUSA Pharma NDA for Erwinaze (asparaginase Erwinia chrysanthemi) to treat certain patients with acute lymphoblasti...